Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has announced an update on its share buyback program, which began on April 30, 2025, following the Shareholders’ Meeting resolution. The program aims to purchase shares to support stock options and performance shares plans for the company’s management. Between July 7 and July 11, 2025, Recordati purchased 75,466 shares at an average price of 53.8449 Euros per share, bringing its total holdings to 3,674,679 shares, representing 1.757% of its share capital. This move is part of Recordati’s broader strategy to enhance its market position and incentivize its management team, potentially impacting shareholder value and market perception.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy from the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, operating in a fully integrated manner from clinical development to production, marketing, and licensing. Recordati is present in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people.
Average Trading Volume: 304,090
Technical Sentiment Signal: Buy
Current Market Cap: €11.14B
For an in-depth examination of REC stock, go to TipRanks’ Overview page.